STOCK TITAN

Director James D. Forbes buys 5,000 DENTSPLY SIRONA (XRAY) shares in market trade

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director James D. Forbes bought 5,000 shares of common stock in an open-market purchase. The shares were acquired at a price of $13.469 per share on 2026-03-03, giving him direct ownership of 5,000 shares following the transaction.

Positive

  • None.

Negative

  • None.
Insider Forbes James D
Role Director
Bought 5,000 shs ($67K)
Type Security Shares Price Value
Purchase Common Stock 5,000 $13.469 $67K
Holdings After Transaction: Common Stock — 5,000 shares (Direct)
Footnotes (1)
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Forbes James D

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28277

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/03/2026 P 5,000 A $13.469 5,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Jessica Nielsen Causey, Attorney-In-Fact for James D. Forbes 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) disclose?

DENTSPLY SIRONA disclosed that director James D. Forbes bought 5,000 common shares. The open-market purchase occurred at $13.469 per share on March 3, 2026, and increased his directly owned stake to 5,000 shares after the transaction.

Who is the insider involved in the latest XRAY Form 4 filing?

The insider is James D. Forbes, a director of DENTSPLY SIRONA Inc. He reported an open-market purchase of 5,000 common shares at $13.469 per share, resulting in direct ownership of 5,000 shares following the reported transaction.

How many DENTSPLY SIRONA (XRAY) shares did James D. Forbes buy?

James D. Forbes bought 5,000 shares of DENTSPLY SIRONA common stock. The Form 4 states this open-market purchase occurred at a price of $13.469 per share and left him holding a total of 5,000 shares directly afterward.

At what price were the XRAY shares purchased in the latest insider trade?

The shares were purchased at $13.469 per share. According to the Form 4, director James D. Forbes acquired 5,000 common shares of DENTSPLY SIRONA in an open-market transaction at that price on March 3, 2026.

What is James D. Forbes’ DENTSPLY SIRONA share ownership after the trade?

After the reported trade, James D. Forbes directly owns 5,000 DENTSPLY SIRONA shares. The Form 4 shows that this entire amount reflects his direct beneficial ownership following the 5,000-share open-market purchase at $13.469 per share.

Was the recent XRAY insider trade a purchase or a sale?

The recent XRAY insider trade was a purchase. The Form 4 identifies transaction code “P” and describes it as an open-market purchase of 5,000 DENTSPLY SIRONA common shares by director James D. Forbes at $13.469 per share.